HDRPF.US Epsilon Healthcare Limited

Healthcare Pharmaceuticals USA Stocks
0.0100 USD
Close of Nov 14, 2026
0.0014 0.0100
Market cap
USD 3.89M
P/E
-
P/B
1.44x
ROE
-55.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is HDRPF.US undervalued?

Graham number

The Graham number of Epsilon Healthcare Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Epsilon Healthcare Limited fundamental analysis

No fundamental analysis for Epsilon Healthcare Limited yet.

Epsilon Healthcare Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Epsilon Healthcare Limited

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision …

Full company profile